Abbott Laboratories (ABT) | Short-term (Operating) Activity Analysis
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Ratios (Summary)
Abbott Laboratories, short-term (operating) activity ratios
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Turnover Ratios | ||||||
| Inventory turnover | 10.51 | 11.83 | 11.03 | 9.42 | 10.64 | |
| Receivables turnover | 5.24 | 5.06 | 4.90 | 4.70 | 5.40 | |
| Payables turnover | 22.19 | 22.57 | 22.90 | 24.02 | 21.85 | |
| Working capital turnover | 2.21 | 4.69 | 6.96 | 3.00 | 5.42 | |
| Average No. of Days | ||||||
| Average inventory processing period | 35 | 31 | 33 | 39 | 34 | |
| Add: Average receivable collection period | 70 | 72 | 75 | 78 | 68 | |
| Operating cycle | 104 | 103 | 108 | 116 | 102 | |
| Less: Average payables payment period | 16 | 16 | 16 | 15 | 17 | |
| Cash conversion cycle | 88 | 87 | 92 | 101 | 85 | |
Source: Based on data from Abbott Laboratories Annual Reports
| Ratio | Description | The company |
|---|---|---|
| Inventory turnover | An activity ratio calculated as revenue divided by inventory. | Abbott Laboratories's inventory turnover improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012. |
| Receivables turnover | An activity ratio equal to revenue divided by receivables. | Abbott Laboratories's receivables turnover improved from 2010 to 2011 and from 2011 to 2012. |
| Payables turnover | An activity ratio calculated as revenue divided by payables. | Abbott Laboratories's payables turnover declined from 2010 to 2011 and from 2011 to 2012. |
| Working capital turnover | An activity ratio calculated as revenue divided by working capital. | Abbott Laboratories's working capital turnover deteriorated from 2010 to 2011 and from 2011 to 2012. |
| Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Abbott Laboratories's average inventory processing period improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012. |
| Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnoverd. | Abbott Laboratories's average receivable collection period improved from 2010 to 2011 and from 2011 to 2012. |
| Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Abbott Laboratories's operating cycle improved from 2010 to 2011 but then slightly deteriorated from 2011 to 2012. |
| Average payables payment period | An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. | Abbott Laboratories's average payables payment period increased from 2010 to 2011 and from 2011 to 2012. |
| Cash conversion cycle | A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. | Abbott Laboratories's cash conversion cycle improved from 2010 to 2011 but then slightly deteriorated from 2011 to 2012. |
ADVERTISEMENT
Inventory Turnover
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||
| Net sales | 39,873,910 | 38,851,259 | 35,166,721 | 30,764,707 | 29,527,552 | |
| Inventories | 3,792,313 | 3,284,249 | 3,188,734 | 3,264,877 | 2,775,849 | |
| Inventory Turnover, Comparison to Industry | ||||||
| Abbott Laboratories1 | 10.51 | 11.83 | 11.03 | 9.42 | 10.64 | |
| Industry, Health Care | 9.83 | 10.67 | 10.56 | 8.38 | 11.01 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Inventory turnover = Net sales ÷ Inventories
= 39,873,910 ÷ 3,792,313 = 10.51
| Ratio | Description | The company |
|---|---|---|
| Inventory turnover | An activity ratio calculated as revenue divided by inventory. | Abbott Laboratories's inventory turnover improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012. |
Receivables Turnover
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||
| Net sales | 39,873,910 | 38,851,259 | 35,166,721 | 30,764,707 | 29,527,552 | |
| Trade receivables, less allowances | 7,612,860 | 7,683,920 | 7,184,034 | 6,541,941 | 5,465,660 | |
| Receivables Turnover, Comparison to Industry | ||||||
| Abbott Laboratories1 | 5.24 | 5.06 | 4.90 | 4.70 | 5.40 | |
| Industry, Health Care | 6.68 | 6.47 | 6.47 | 6.01 | 6.76 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Receivables turnover = Net sales ÷ Trade receivables, less allowances
= 39,873,910 ÷ 7,612,860 = 5.24
| Ratio | Description | The company |
|---|---|---|
| Receivables turnover | An activity ratio equal to revenue divided by receivables. | Abbott Laboratories's receivables turnover improved from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Payables Turnover
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||
| Net sales | 39,873,910 | 38,851,259 | 35,166,721 | 30,764,707 | 29,527,552 | |
| Trade accounts payable | 1,796,990 | 1,721,127 | 1,535,759 | 1,280,542 | 1,351,436 | |
| Payables Turnover, Comparison to Industry | ||||||
| Abbott Laboratories1 | 22.19 | 22.57 | 22.90 | 24.02 | 21.85 | |
| Industry, Health Care | 12.47 | 13.18 | 13.35 | 12.41 | 13.43 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Payables turnover = Net sales ÷ Trade accounts payable
= 39,873,910 ÷ 1,796,990 = 22.19
| Ratio | Description | The company |
|---|---|---|
| Payables turnover | An activity ratio calculated as revenue divided by payables. | Abbott Laboratories's payables turnover declined from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Working Capital Turnover
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in thousands) | ||||||
| Current assets | 31,322,583 | 23,768,774 | 22,317,529 | 23,313,891 | 17,042,559 | |
| Less: Current liabilities | 13,280,176 | 15,480,228 | 17,262,434 | 13,049,489 | 11,591,908 | |
| Working capital | 18,042,407 | 8,288,546 | 5,055,095 | 10,264,402 | 5,450,651 | |
| Net sales | 39,873,910 | 38,851,259 | 35,166,721 | 30,764,707 | 29,527,552 | |
| Working Capital Turnover, Comparison to Industry | ||||||
| Abbott Laboratories1 | 2.21 | 4.69 | 6.96 | 3.00 | 5.42 | |
| Industry, Health Care | 4.80 | 4.61 | 4.22 | 3.78 | 5.91 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Working capital turnover = Net sales ÷ Working capital
= 39,873,910 ÷ 18,042,407 = 2.21
| Ratio | Description | The company |
|---|---|---|
| Working capital turnover | An activity ratio calculated as revenue divided by working capital. | Abbott Laboratories's working capital turnover deteriorated from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Average Inventory Processing Period
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Inventory turnover | 10.51 | 11.83 | 11.03 | 9.42 | 10.64 | |
| Average Inventory Processing Period (no. of days), Comparison to Industry | ||||||
| Abbott Laboratories1 | 35 | 31 | 33 | 39 | 34 | |
| Industry, Health Care | 37 | 34 | 35 | 44 | 33 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 10.51 = 35
| Ratio | Description | The company |
|---|---|---|
| Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Abbott Laboratories's average inventory processing period improved from 2010 to 2011 but then deteriorated significantly from 2011 to 2012. |
Average Receivable Collection Period
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Receivables turnover | 5.24 | 5.06 | 4.90 | 4.70 | 5.40 | |
| Average Receivable Collection Period (no. of days), Comparison to Industry | ||||||
| Abbott Laboratories1 | 70 | 72 | 75 | 78 | 68 | |
| Industry, Health Care | 55 | 56 | 56 | 61 | 54 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 5.24 = 70
| Ratio | Description | The company |
|---|---|---|
| Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnoverd. | Abbott Laboratories's average receivable collection period improved from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Operating Cycle
No. of days
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 35 | 31 | 33 | 39 | 34 | |
| Average receivable collection period | 70 | 72 | 75 | 78 | 68 | |
| Operating Cycle, Comparison to Industry | ||||||
| Abbott Laboratories1 | 104 | 103 | 108 | 116 | 102 | |
| Industry, Health Care | 92 | 91 | 91 | 104 | 87 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Operating cycle = Average inventory processing period + Average receivable collection period
= 35 + 70 = 104
| Ratio | Description | The company |
|---|---|---|
| Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Abbott Laboratories's operating cycle improved from 2010 to 2011 but then slightly deteriorated from 2011 to 2012. |
Average Payables Payment Period
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Payables turnover | 22.19 | 22.57 | 22.90 | 24.02 | 21.85 | |
| Average Payables Payment Period (no. of days), Comparison to Industry | ||||||
| Abbott Laboratories1 | 16 | 16 | 16 | 15 | 17 | |
| Industry, Health Care | 29 | 28 | 27 | 29 | 27 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 22.19 = 16
| Ratio | Description | The company |
|---|---|---|
| Average payables payment period | An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. | Abbott Laboratories's average payables payment period increased from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Cash Conversion Cycle
No. of days
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data | ||||||
| Average inventory processing period | 35 | 31 | 33 | 39 | 34 | |
| Average receivable collection period | 70 | 72 | 75 | 78 | 68 | |
| Average payables payment period | 16 | 16 | 16 | 15 | 17 | |
| Cash Conversion Cycle, Comparison to Industry | ||||||
| Abbott Laboratories1 | 88 | 87 | 92 | 101 | 85 | |
| Industry, Health Care | 62 | 63 | 64 | 75 | 60 | |
Source: Based on data from Abbott Laboratories Annual Reports
2012 Calculations
1 Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 35 + 70 – 16 = 88
| Ratio | Description | The company |
|---|---|---|
| Cash conversion cycle | A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. | Abbott Laboratories's cash conversion cycle improved from 2010 to 2011 but then slightly deteriorated from 2011 to 2012. |





